These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2068058)

  • 21. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
    Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
    Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correspondence re: J. D. Seidman, J. J. Berman, and G. W. Moore. Basal cell carcinoma: importance of histologic discontinuities in the evaluation of resection margins. Mod Pathol 4:325, 1991.
    Peterson AP
    Mod Pathol; 1991 Nov; 4(6):773. PubMed ID: 1788269
    [No Abstract]   [Full Text] [Related]  

  • 23. [Problems and planning of excision of large basaliomas].
    Breuninger H
    Z Hautkr; 1987 Feb; 62(4):269-79. PubMed ID: 3577289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
    Valdes EK; Boolbol SK; Cohen JM; Feldman SM
    Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the microscopic tumor extent beyond clinically delineated gross tumor boundary in nonmelanoma skin cancers?
    Choo R; Woo T; Assaad D; Antonyshyn O; Barnes EA; McKenzie D; Fialkov J; Breen D; Mamedov A
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1096-9. PubMed ID: 15990014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Margin involvement after the excision of melanoma in situ: the need for complete en face examination of the surgical margins.
    Kimyai-Asadi A; Katz T; Goldberg LH; Ayala GB; Wang SQ; Vujevich JJ; Jih MH
    Dermatol Surg; 2007 Dec; 33(12):1434-9; discussion 1439-41. PubMed ID: 18076608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
    Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
    J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma.
    Scopa CD; Aroukatos P; Tsamandas AC; Aletra C
    Breast J; 2006; 12(2):150-3. PubMed ID: 16509840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of basal cell carcinomas with positive margins].
    Ríos-Buceta L
    Actas Dermosifiliogr; 2007 Dec; 98(10):679-87. PubMed ID: 18035025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of subclinical tumor infiltration in basal cell carcinoma.
    Breuninger H; Dietz K
    J Dermatol Surg Oncol; 1991 Jul; 17(7):574-8. PubMed ID: 1860987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
    Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
    J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
    Hamada S; Kersey T; Thaller VT
    Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of surgical margins in Basal cell carcinoma by surgical specialty.
    Bassas P; Hilari H; Bodet D; Serra M; Kennedy FE; García-Patos V
    Actas Dermosifiliogr; 2013 Mar; 104(2):133-40. PubMed ID: 22835227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma.
    Cheretis C; Angelidou E; Dietrich F; Politi E; Kiaris H; Koutselini H
    Med Sci Monit; 2008 May; 14(5):MT13-19. PubMed ID: 18443558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of periocular basal cell carcinoma managed by overnight paraffin section.
    Khandwala MA; Lalchan SA; Chang BY; Habib M; Chakrabarty A; Cassells-Brown A
    Orbit; 2005 Dec; 24(4):243-7. PubMed ID: 16354633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative assessment of basal cell carcinoma using conventional fluorescence diagnosis.
    Neus S; Gambichler T; Bechara FG; Wöhl S; Lehmann P
    Arch Dermatol Res; 2009 Apr; 301(4):289-94. PubMed ID: 18979108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant androgen withdrawal therapy decreases local recurrence rates following tumor excision in the Shionogi tumor model.
    Gleave ME; Sato N; Goldenberg SL; Stothers L; Bruchovsky N; Sullivan LD
    J Urol; 1997 May; 157(5):1727-30. PubMed ID: 9112514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
    Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.